Company / Capital Returned to Shareholders
CLOVER HEALTH INVESTMENTS, CORP. /DE Capital Returned to Shareholders History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$18.3M
FY2025
5-year range
$0 / $18.3M
FY2021-FY2025
Trend
+932.6%
vs FY2024
Sector context
#82 of 108
Health Care
What the data says
Capital Returned to Shareholders changed +933% YoY in FY2025, a notable deviation from the 2-year average annual change of +416%.
Based on SEC 10-K filings.
$18M in FY2025.
Improved from $0 to $18M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 108This company $18.3M Sector average $754.9M
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders increased 932.6% year-over-year.
- Ranks #82 out of 108 companies in the Health Care sector.
- Lowest capital returned to shareholders in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.3M | +932.6% |
| FY2024 | $1.8M | - |
| FY2023 | $0 | - |
| FY2022 | $0 | -100.0% |
| FY2021 | $147.0K | - |
| FY2020 | $0 | - |
| FY2019 | $0 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026